Condition: Breast Cancer · Chemo-brain · Endocrine Therapy · Sponsor: Tang-Du Hospital
To explore the cognitive impairment caused by chemotherapy and endocrine therapy in premenopausal breast cancer patients and to find biomarkers with early predictive effect on this cognitive impairment by using multimodal integrated PET/MRI technology combined with psychobehavioral technology.
This description comes directly from the study's public registry record.
Menghui Yuan, phd · 0086-13519196610 · yuanmenghui@163.com
Lijun Bai, phd · 0086-15129034948 · bailijun@xjtu.edu.cn
Always discuss trial participation with your own doctor first.
| Tangdu Hospital | Xi'an, Shaanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05305092